T
|
| T scores |
|
 |
|
| T4 (thyroxine) |
|
 |
| enteral nutrition interactions |
|
 |
| and osteoporosis |
|
 |
| prescribing information for hypothyroidism |
|
 |
| prescribing information for myxedema coma |
|
 |
|
| Tachycardia, atrial (Table) |
|
 |
|
| Tacrolimus (Table) |
|
 |
|
| Tadalafil (Cialis) |
|
 |
| for BPH |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for male sexual dysfunction (Table) |
|
 |
|
| Tagamet |
|
 |
| See also Cimetidine |
|
 |
| prescribing information for GERD (Table) |
|
 |
|
| Tai Chi |
|
 |
| exercise prescription |
|
 |
| for preventing falls (Table) |
|
 |
|
| Take Control |
|
 |
|
| Tamiflu (oseltamivir) (Table) |
|
 |
|
| Tamoxifen (Nolvadex) |
|
 |
| for breast cancer |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for breast cancer (Table) |
|
 |
| prescribing information for breast cancer prevention |
|
 |
|
| Tamsulosin (Flomax) |
|
 |
|
| Tapazole (methimazole) |
|
 |
|
| Tar |
|
 |
| for psoriasis |
|
 |
| for seborrheic dermatitis |
|
 |
|
| Tardive dyskinesia (TD) (Table) |
|
 |
|
| Tarka (verapamil with trandolapril) (Table) |
|
 |
|
| Tasmar (tolcapone) |
|
 |
|
| Tazobactam-piperacillin (Zosyn) |
|
 |
| for community-acquired pneumonia (Table) |
|
 |
| for nursing-home or hospital-acquired pneumonia |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| TB (tuberculosis) |
|
 |
| Tuberculosis section |
|
 |
| identification of high-risk patients (Table) |
|
 |
| treatment of active infection (Table) |
|
 |
| treatment of latent infection (Table) |
|
 |
|
| TCAs (tricyclic antidepressants) |
|
 |
| for bipolar disorders (Table) |
|
 |
| and dementia |
|
 |
| fall risks |
|
 |
| for IBS |
|
 |
| for pain relief (Table) |
|
 |
| for painful neuropathy |
|
 |
| for persistent pain (Table) |
|
 |
| prescribing information for depression (Table) |
|
 |
| for restless legs syndrome |
|
 |
|
| T-cell activation inhibitors |
|
 |
|
| TD (tardive dyskinesia) (Table) |
|
 |
|
| TDD (telephone device for the deaf) |
|
 |
|
| Tegaderm |
|
 |
| See also Transparent film |
|
 |
| prescribing information for pressure ulcers (Table) |
|
 |
|
| Tegasorb |
|
 |
| See also Hydrocolloids |
|
 |
| prescribing information for pressure ulcers (Table) |
|
 |
|
| Tegretol |
|
 |
| See also Carbamazepine |
|
 |
| prescribing information for agitation (Table) |
|
 |
| prescribing information for bipolar disorders (Table) |
|
 |
| prescribing information for painful neuropathy |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Tegretol XR |
|
 |
| See also Carbamazepine |
|
 |
| prescribing information for bipolar disorders (Table) |
|
 |
| prescribing information for painful neuropathy |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Telephone device for the deaf (TDD) |
|
 |
|
| Telithromycin (Ketek) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Telmisartan (Micardis) |
|
 |
| with HCTZ (Micardis HCT) (Table) |
|
 |
| prescribing information for HTN (Table) |
|
 |
| target dosage in HF (Table) |
|
 |
|
| Temazepam (Restoril) |
|
 |
| daily dose thresholds (Table) |
|
 |
| prescribing information for sleep disorders (Table) |
|
 |
|
| Temovate |
|
 |
| See also Clobetasol propionate |
|
 |
| prescribing information for dermatologic conditions (Table) |
|
 |
|
| Temperature conversions (Table) |
|
 |
|
| Temporal (giant cell) arteritis |
|
 |
|
| Tendinitis |
|
 |
| bicipital |
|
 |
| rotator cuff |
|
 |
|
| Tenex (guanfacine) (Table) |
|
 |
|
| Tenoretic (atenolol with chlorthalidone) (Table) |
|
 |
|
| Tenormin |
|
 |
| See also Atenolol |
|
 |
| prescribing information for acute MI |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Tequin |
|
 |
| See also Gatifloxacin |
|
 |
| prescribing information for acute bacterial conjunctivitis (Table) |
|
 |
|
| Terazosin (Hytrin) |
|
 |
| prescribing information for BPH |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Terbinafine (Lamisil, Lamisil AT) |
|
 |
| prescribing information for dermatologic conditions (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
| prescribing information for onychomycosis |
|
 |
|
| Teriparatide (Forteo) |
|
 |
| bone outcomes (Table) |
|
 |
| prescribing information for osteoporosis |
|
 |
|
| Tessalon Perles (benzonatate) (Table) |
|
 |
|
| Testim (testosterone gel) (Table) |
|
 |
|
| Testoderm (testosterone) (Table) |
|
 |
|
| Testosterone |
|
 |
| scrotal transdermal (Testoderm) (Table) |
|
 |
| skin transdermal (Androderm) (Table) |
|
 |
|
| Testosterone cypionate or enanthate (Table) |
|
 |
|
| Testosterone gel (AndroGel, Testim) (Table) |
|
 |
|
| Tests, preventive (Table) |
|
 |
|
| Tetanus immunization (Table) |
|
 |
|
| Tetracosactin (Synacthen Depot) |
|
 |
|
| Tetracycline (Achromycin, Helidac, Sumycin) |
|
 |
| for cellulitis |
|
 |
| digoxin interactions |
|
 |
| prescribing information for H pylori-induced ulcerations (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
| prescribing information for peptic ulcer disease |
|
 |
| prescribing information for rosacea |
|
 |
|
| Teveten |
|
 |
| See also Eprosartan |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Teveten HCT (eprosartan mesylate with HCTZ) (Table) |
|
 |
|
| Thalamotomy |
|
 |
|
| Theo-24 |
|
 |
| See also Theophylline-SR |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Theo-Dur |
|
 |
| See also Theophylline-SR |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Theophylline |
|
 |
|
| Theophylline-SR (Quibron-T/SR, Slo-Bid, Theo-24, Theo-Dur, Uniphyl) |
|
 |
| for asthma (Table) |
|
 |
| for COPD (Table) |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Thiamine |
|
 |
|
| Thiazide diuretics |
|
 |
| and coexisting conditions (Table) |
|
 |
| for HTN |
|
 |
| for hyperkalemia |
|
 |
| for hyperkalemia inpatient management |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Thiazolidinediones |
|
 |
| for diabetes mellitus type 2 |
|
 |
| prescribing information for diabetes mellitus (Table) |
|
 |
| and UI (Table) |
|
 |
|
| Thickening agents |
|
 |
|
| Thioridazine (Mellaril) |
|
 |
| daily dose thresholds (Table) |
|
 |
| for delirium |
|
 |
| and dementia |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for psychosis (Table) |
|
 |
|
| Thiotepa (Table) |
|
 |
|
| Thiothixene (Table) |
|
 |
|
| Third-spacing |
|
 |
|
| Thirst, impaired |
|
 |
|
| Thorazine (chlorpromazine) |
|
 |
| See also Chlorpromazine |
|
 |
| for delirium |
|
 |
|
| Thrombin inhibitors (Table) |
|
 |
|
| Thrombocytopenia, heparin-induced (Table) |
|
 |
|
| Thrombocytosis, essential |
|
 |
|
| Thrombolytic therapy |
|
 |
| for acute MI |
|
 |
| for acute stroke |
|
 |
| for anticoagulation (Table) |
|
 |
| for PE |
|
 |
| for Q-wave MI |
|
 |
|
| Thrombosis |
|
 |
| deep-vein (DVT) |
|
 |
| anticoagulation for prophylaxis and treatment (Table) |
|
 |
| anticoagulation in absence of active bleeding or severe bleeding risk (Table) |
|
 |
| medications for osteoporosis and risk of (Table) |
|
 |
| prophylaxis |
|
 |
| prophylaxis and treatment |
|
 |
| idiopathic venous (Table) |
|
 |
|
| Thyroid nodules |
|
 |
|
| Thyroid-stimulating hormone (TSH) (Table) |
|
 |
|
| Thyroxine (T4) |
|
 |
| enteral nutrition interactions |
|
 |
| and osteoporosis |
|
 |
| prescribing information for hypothyroidism |
|
 |
| prescribing information for myxedema coma |
|
 |
|
| TIA (transient ischemic attack) |
|
 |
| crescendo |
|
 |
| and dizziness (Table) |
|
 |
| management of |
|
 |
|
| Tiagabine (Gabitril Filmtabs) (Table) |
|
 |
|
| Tiazac (diltiazem) (Table) |
|
 |
|
| Ticar (ticarcillin) (Table) |
|
 |
|
| Ticarcillin (Ticar) (Table) |
|
 |
|
| Ticarcillinclavulanate (Timentin) (Table) |
|
 |
|
| Ticlid |
|
 |
| See also Ticlopidine |
|
 |
| prescribing information for stroke prevention |
|
 |
|
| Ticlopidine (Ticlid) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for stroke prevention |
|
 |
|
| Tigecycline (Tygacil) (Table) |
|
 |
|
| Tilade |
|
 |
| See also Nedocromil |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Tilt-table testing |
|
 |
|
| Timentin (ticarcillin-clavulanate) (Table) |
|
 |
|
| Timolide (timolol maleate with HCTZ) (Table) |
|
 |
|
| Timolol (Blocadren) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Timolol drops (Betimol, Timoptic) (Table) |
|
 |
|
| Timolol maleate with HCTZ (Timolide) (Table) |
|
 |
|
| Timolol/dorzolamide (Cosopt) (Table) |
|
 |
|
| Timoptic (timolol drops) (Table) |
|
 |
|
| Tinactin (tolnaftate) (Table) |
|
 |
|
| Tinea corpis (Table) |
|
 |
|
| Tinea cruris (Table) |
|
 |
|
| Tinea pedis (Table) |
|
 |
|
| Tinea unguium |
|
 |
|
| Tinea versicolor (Table) |
|
 |
|
| Tinnitus |
|
 |
|
| Tinzaparin (Innohep) |
|
 |
| for DVT/PE prophylaxis and treatment |
|
 |
| prescribing information for DVT or PE prophylaxis and treatment (Table) |
|
 |
|
| Tiotropium (Table) |
|
 |
|
| Tirofiban (Aggrastat) (Table) |
|
 |
|
| Titanium |
|
 |
|
| TMP/SMZ (trimethoprim/sulfamethoxazole) |
|
 |
| double strenght (DS) |
|
 |
| for pertussis (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Tobacco abuse |
|
 |
| See also Smoking |
|
 |
| pharmacotherapy for (Table) |
|
 |
|
| Tobramycin (AKTob, Nebcin, Tobrex) |
|
 |
| for nursing-home or hospital-acquired pneumonia |
|
 |
| prescribing information for acute bacterial conjunctivitis (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Tobrex |
|
 |
| See also Tobramycin |
|
 |
| prescribing information for acute bacterial conjunctivitis (Table) |
|
 |
|
| Tofranil |
|
 |
| See also Imipramine |
|
 |
| avoid use |
|
 |
|
| Toilet training |
|
 |
|
| Tolbutamide |
|
 |
| digoxin interactions |
|
 |
| drug and metabolic interactions (Table) |
|
 |
|
| Tolcapone (Tasmar) (Table) |
|
 |
|
| Tolectin |
|
 |
| See also Tolmetin |
|
 |
| prescribing information for arthritis (Table) |
|
 |
|
| Tolmetin (Tolectin) |
|
 |
| prescribing information for arthritis (Table) |
|
 |
| warfarin interactions |
|
 |
|
| Tolnaftate (Absorbine Jr. Antifungal, Tinactin) (Table) |
|
 |
|
| Tolterodine (Detrol, Detrol LA) (Table) |
|
 |
|
| Topamax (topiramate) (Table) |
|
 |
|
| Topicort (desoximetasone) |
|
 |
| prescribing information for dermatologic conditions (higher potency) (Table) |
|
 |
| prescribing information for dermatologic conditions (mid-potency) (Table) |
|
 |
|
| Topiramate (Topamax) (Table) |
|
 |
|
| Toprol XL (metoprolol XL) |
|
 |
| prescribing information for HF |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Toradol |
|
 |
| See also Ketorolac |
|
 |
| prescribing information for arthritis (Table) |
|
 |
|
| Toremifene (Fareston) (Table) |
|
 |
|
| Tornalate (bitolterol) (Table) |
|
 |
|
| Torsemide (Demadex) |
|
 |
| for hyperkalemia |
|
 |
| for hyperkalemia inpatient management |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Total body water |
|
 |
|
| Total joint replacement |
|
 |
| anticoagulation for DVT or PE prophylaxis and treatment (Table) |
|
 |
| anticoagulation in absence of active bleeding or severe bleeding risk (Table) |
|
 |
| endocarditis prophylaxis |
|
 |
| for hip fracture |
|
 |
| for osteoarthritis |
|
 |
|
| Total parenteral nutrition |
|
 |
|
| Trabeculectomy |
|
 |
|
| Tracheostomy |
|
 |
|
| Tramadol (Ultram) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| for osteoarthritis (algorithm) (Figure) |
|
 |
| prescribing information for pain (Table) |
|
 |
| prescribing information for painful neuropathy |
|
 |
|
| Tramadol with APAP (Ultracet) |
|
 |
| for pain management |
|
 |
| |